CClinicalTrials.gg
Status unknownNCT05556317Updated Sep 27, 2022

Effect of Resistive Exercise on Insomnia in Post Menopausal Women

An interventional study of Resistive exercise in Sleep Disturbances and Insomnia, sponsored by Cairo University. Status unknown at 1 site in Egypt. Open to female participants aged 50 Years to 65 Years. Per ClinicalTrials.gov, last updated 2022-09-27.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Sep 2022), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
56
Allocation
Randomized
Ages
50 Years to 65 Years
Sex
Female
01

Study summary

the aim of this study is to investigate the efficacy of resistive exercise on insomnia in post menopausal women

Read the detailed description

Insomnia is a prevalent condition in post menopausal women.resistive exercise might play an important role in insomnia.this trial has two groups ;one will receive advices and the second will receive advices and resistive exercise for four week

02

Conditions studied

  • Sleep Disturbances and Insomnia

Keywords

  • Resistive exercise, insomnia, post menopausal women
03

In context

Sleep Initiation and Maintenance Disorders

1,856 studies on the registry are indexed under Sleep Initiation and Maintenance Disorders; 594 are open to participants now.

This study's planned enrollment of 56 is below the median of 73 across 1,631 interventional studies indexed under Sleep Initiation and Maintenance Disorders.

Browse Sleep Initiation and Maintenance Disorders studies →

Lead sponsor

Cairo University is the lead sponsor of 4,780 studies on the registry; 1,427 are open to participants now.

Of its 36 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years to 65 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  1. age from 50 to 65 years
  2. non smokers
  3. BMI 25:29.9
  4. post menopausal women suffer from insomnia

Exclusion criteria

Exclusion Criteria:

  1. post menopausal women suffer from any medical problems lead to sleep disturbance and insomnia
  2. women on hormone replacement therapy
  3. those with diagnosed osteoporosis
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
56 participants (estimated)

Study arms

  • Experimental
    Group A

    Receive advices to reduce insomnia

    Behavioral: Resistive exercise

  • Active comparator
    Group B

    Receive advices and resistive exercise

    Behavioral: Resistive exercise

Interventions

  • BehavioralResistive exercise

    advices and resistive exercise

06

What researchers measure

Primary outcomes

  1. Pittsburgh sleep quality index

    To determine sleep quality

    Time frame: Four week

Secondary outcomes

  1. Insomnia severity index

    To determine insomnia

    Time frame: Four week

Other outcomes

  1. Plasma estradiol

    To determine level of plasma estradiol

    Time frame: Four week

07

Study locations

1 of 1 sites recruiting
  • Professor of physical therapy
    Cairo, Egypt
    Recruiting
08

References and documents

Individual participant data

Plan to share: Yes

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 27, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05556317
Lead sponsor
Cairo University
Responsible party
Esraa Fikry Massoud Yamani (esraa fikry massoud yamani, Cairo University) — Principal investigator
First posted
Sep 27, 2022
Start date
Sep 30, 2022 (estimated)
Primary completion
Nov 1, 2022 (estimated)
Completion
Nov 15, 2022 (estimated)
Last update
Sep 27, 2022

Study contacts

Esraa Fikry Massoud, Master
Contact
fikryesraa148@gmail.com
01555358802

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Sep 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion